Boston Children’s Hospital is a world leader in pediatric respiratory diseases, including interstitial lung disease (ILD or chILD). We specialize in innovative, family-centered care that supports you at every step on your child’s journey to health.

Read the study, “Genotype–Phenotype Correlations for Infants and Children with ABCA3 Deficiency,” which identifies a specific genotype in pediatric patients with the autosomal recessive condition, ABCA3 deficiency.

Inside Boston Children’s Interstitial Lung Disease Program

Our ILD program is part of the Children's Interstitial Lung Disease Research Network (chILDRN) and is designated as a center of excellence by the Children's Interstitial Lung Disease (chILD) Foundation.

Staffed by a multidisciplinary team of clinicians, we provide comprehensive services ranging from evaluation and diagnosis, to treatment and patient education.

For more information about Boston Children’s Interstitial Lung Disease Program and our ongoing ILD research or the Division of Pulmonary and Respiratory Diseases, call 617-355-1900.

Get the facts.

Download the paper published in the AJRCCM.